Poll finds very mixed views on morning-after pill; black/white breast cancer disparities widen

Several stories this morning examine tricky problems in women's health care.

NPR: Poll: Americans Favor Age Restrictions On Morning-After Pill
First, we found out [in the NPR-Truven Health Analytics Health Poll] that most people are familiar that there is a morning-after pill. ... Eighteen percent said there should be no age minimum. Around the same proportion -; 17 percent -; said a prescription should always be required, regardless of the buyer's age. ... About two-thirds of respondents believe that parents should have to give their permission before anyone under 18 buys the morning-after pill without a prescription. That's not a requirement now. ... Finally, most Americans believe insurers should pay for the morning-after pill(Hensley, 12/19).

The New York Times: Tackling A Racial Gap In Breast Cancer Survival
Despite 20 years of pink ribbon awareness campaigns and numerous advances in medical treatment that have sharply improved survival rates for women with breast cancer in the United States, the vast majority of those gains have largely bypassed black women. ... In the 1980s, breast cancer survival rates for the two were nearly identical. But since 1991, as improvements in screening and treatment came into use, the gap has widened, with no signs of abating. Although breast cancer is diagnosed in far more white women, black women are far more likely to die of the disease  (Parker-Pope, 12/20).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

 

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Scientists map cancer mutations in EGFR gene, revealing drug resistance paths